MÉTHODE DE DIAGNOSTIC DES HÉMOPATHIES MALIGNES ET KIT ASSOCIÉ

European patent · EP3044331 · In force

Register entry

Publication number
EP3044331
Application number
EP14781927
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 11, 2014
Published
Jul 20, 2016
Granted
Mar 11, 2020
Protection ends at the latest
Sep 10, 2034
Next annual fee due
Sep 30, 2027
IPC classes
C12Q 1/6886 (2018.01)
Priority
FR 1358721 11.09.2013
PCT application
PCT/FR2014/052255 11.09.2014
PCT publication
WO2015/036705 19.03.2015
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  6. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  7. May 8, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 08.05.2020

  8. Mar 11, 2020

    Granted

    Published in Swissreg on 11.03.2020

Parties

Inventor

JARDIN, Fabrice

F-76000 Rouen, FR

MARCHAND, Vinciane

F-76000 Rouen, FR

RUMINY, Philippe

F-76000 Rouen, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.